Needham Upgrades Globus Medical (GMED) to Buy, 'Analysis Indicates Earnings Upside & Favorable Risk/Reward'
Tweet Send to a Friend
(Updated - January 30, 2026 6:45 AM EST)
Needham analyst Mike Matson upgraded Globus Medical (NYSE: GMED) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Mike Matson upgraded Globus Medical (NYSE: GMED) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
